Simbioen Labs and Scientific Services

What Simbioen Labs and Scientific Services does

Simbioen Labs and Scientific Services Private Limited is a Chennai-based biotechnology micro-CRO founded in 2017 by Prashanth K K. The company provides preclinical drug discovery services built around an alternative animal model panel that includes zebrafish, Artemia, Drosophila, C. elegans, Daphnia magna, algae toxicity assays, bacteriophage work, AMES mutagenicity, haemolysis, and Saccharomyces cerevisiae — positioning it as a lower-cost, more ethical substitute for traditional rodent-based preclinical testing. Service offerings span in-silico testing, in-vitro mammalian and stem cell culture work, in-vivo zebrafish studies, histopathology, phytochemistry, microbiology, molecular biology, and bioinformatics. These services are organized under three branded centres of excellence: the Centre for Preclinical Drug Discovery (CPDD), Centre for Advanced Bioinformatics (CAB), and Centre for Organic and Natural Chemistry (CONC), supplemented by in-house semi-synthetic and histopathology laboratories.

The business operates on a project-based, quote-priced professional services model with no public pricing tiers. Customer segments are overwhelmingly academic: PhD candidates, university research scholars, and college students from institutions across Tamil Nadu, with secondary exposure to pharmaceutical and biotech firms. The company is physically anchored inside the Crescent Innovation and Incubation Council at B S Abdur Rahman Crescent Institute, and maintains 10+ MOUs with universities and colleges including SRM, Vels, AVIT, Chettinad, and Tagore, plus an international research partnership with the University of Southampton. Go-to-market is sales-led, driven by direct inquiry, academic referrals, and on-campus training workshops. Funding to date consists of INR 30 lakhs in government research grants and recognition under the Startup India Seed Fund Scheme; no institutional venture capital is recorded, and the company remains founder-owned with 1-10 employees.

Name

Simbioen Labs and Scientific Services

Legal name

SIMBIOEN LABS AND SCIENTIFIC SERVICES PRIVATE LIMITED

Website

https://simbioen.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Simbioen Labs is a Chennai-based micro-CRO providing preclinical drug discovery services using alternative animal models (zebrafish, Drosophila, C. elegans), bioinformatics, and phytochemistry to academic researchers, PhD candidates, and small biotech clients in India.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Preclinical Drug Discovery Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industry

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Preclinical drug discovery
• Contract research services
• Alternative animal models
• Bioinformatics services
• Biotechnology research

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. CRO Services - Testing and Assays: Contract research organization providing fee-for-service preclinical testing across multiple disciplines including microbiology, bioinformatics, animal models, biochemistry, molecular biology, and histopathology. Services are offered on a project basis with customized quotations based on assay requirements.
2. Training Services: Online and in-plant training programs for students and professionals in scientific techniques including molecular docking, nanoparticle synthesis, chromatography, and other laboratory methods.
3. Research Support Services: Academic and educational research support including publication support, thesis work assistance, and research project collaboration with universities and institutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Simbioen Labs is a Contract Research Organization (CRO) that provides preclinical drug discovery services using alternative animal models including Zebrafish, Artemia, Drosophila, C.elegans, and Daphnia magna. The company offers in-vitro and in-vivo testing, insilico (computational) testing, molecular docking, histopathology, phytochemistry, and mammalian cell culture services to pharmaceutical, biotech, and academic clients. It also runs online and in-plant training programs for students and researchers across life sciences.

Product overview

SimBioen Labs and Scientific Services Private Limited is a biotechnology startup established in 2017, providing preclinical drug discovery platform-based solutions. The company operates as a unified CRO (Contract Research Organization) offering integrated services across multiple scientific domains including scientific writing, insilico testing, in-vitro testing, and in-vivo testing. The company manages three specialized research centers: the Centre for Organic and Natural Chemistry (CONC) focused on sustainable natural product synthesis; the Centre for Advanced Bioinformatics (CAB) for computational biology; and the Centre for Preclinical Drug Discovery (CPDD) offering comprehensive alternate animal model-based testing. The portfolio also includes training programs (online and inplant), contract research services, product development support, and academic research assistance. The company supports research across phytochemistry, industrial microbiology, polymer chemistry, and nano-biotechnology.

Differentiator

Problem solved

Functional benefit

Brands

• Centre for Preclinical Drug Discovery (CPDD): Centre dedicated to exploring alternative approaches to animal studies, promoting humane and ethical methods of animal research using alternate animal models.
• Centre for Advanced Bioinformatics (CAB)
• Centre for Organic and Natural Chemistry (CONC)

Products and services

• Scientific Writing Services
• Insilico Testing Services
• In-vitro Testing Services
• In-vivo Testing Services
• Contract Research Services
• Product Development Centre Services
• Online Training Programs
• Inplant Training Programs
• Academic/Educational Research Support

Quantifiable outcome

• 30 lakhs in government research grants secured
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Srimuthu Kumaren CollegeminorStrategic or Co-development Partner · 27 July 2025MOU signed with Srimuthu Kumaren College for academic collaboration.
• KVCETminorStrategic or Co-development Partner · 7 February 2025MOU signed with KVCET (Kongu Varadaraja College of Engineering and Technology) for academic and research collaboration.
• Chettinad CAREminorStrategic or Co-development Partner · 15 October 2023MOU signed with Chettinad CARE hospital for research and training collaboration.
• Vels UniversitycoreStrategic or Co-development Partner · 15 October 2023MOU signed with Vels University for academic collaboration and training programs.
• AVIT VMRFcoreStrategic or Co-development Partner · 11 June 2023MOU signed with AVIT (Aalim Muhammed Salegh College of Engineering) VMRF for academic and research collaboration.
• University of Southampton, UKcoreStrategic or Co-development Partner · 1 January 2017Collaborated as project partner with University of Southampton, UK on 'Design and development of novel stents for cardiovascular disorders' - an international research collaboration demonstrating cross-border research capabilities.
• Crescent UniversitycoreStrategic or Co-development PartnerVarious collaborative projects, workshops and training conducted with Crescent University. Organization's lab facility is located within Crescent Innovation and Incubation Council at B S Abdur Rahman Institute of Science and Technology.
• Sri Ramachandra Medical College and HospitalcoreStrategic or Co-development PartnerCollaborative projects and training programs conducted with Sri Ramachandra Medical College and Hospital for research and educational purposes.
• SRM Medical College and HospitalcoreStrategic or Co-development PartnerMultiple workshops and training programs conducted with SRM Medical College and Hospital including SRM ISPCON event participation.
• Tagore Medical and Dental CollegeminorStrategic or Co-development PartnerCollaborative workshops and training conducted with Tagore Medical and Dental College.
• Balaji Dental CollegeminorStrategic or Co-development PartnerTraining programs conducted with Balaji Dental College including student training sessions.
• Mahatma Gandhi Medical CollegeminorStrategic or Co-development PartnerCollaborative workshops and training programs with Mahatma Gandhi Medical College.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Aragen Life Sciences (formerly GVK Bio): Large Hyderabad-based CRO offering discovery, preclinical, and development services. Comparable because it provides contract preclinical and drug discovery services to pharma/biotech, though at far greater scale and with full GLP infrastructure compared with Simbioen's micro-CRO model.
• Anthem Biosciences: Bengaluru-based CRO/CDMO with integrated drug discovery, preclinical and manufacturing services. Comparable as an India-headquartered preclinical CRO serving global pharma, but with substantially larger scale, GLP facilities, and broader therapeutic-area coverage than Simbioen.
• Syngene International: Publicly listed Indian CRO offering discovery, preclinical, and clinical research services. Directly comparable in service category (preclinical CRO for global sponsors) but vastly larger, with established GLP facilities and a multinational sponsor base.
• Sai Life Sciences: Hyderabad-based CRO providing drug discovery, preclinical, and CMC services. Comparable because it is an India-based preclinical CRO competing for outsourced discovery work, but at significantly greater scale with established regulated infrastructure.
• Jubilant Biosys: Contract discovery and preclinical research subsidiary of Jubilant Life Sciences. Comparable in providing preclinical and discovery CRO services to pharma, but with broader therapeutic reach and more established sponsor relationships.
• Eurofins Discovery: Global discovery CRO with extensive in-vitro, in-vivo, and ADME-Tox capabilities including zebrafish and alternative model assays. Comparable because it offers preclinical testing services using similar alternate animal models, but operates globally at much larger scale.
• Charles River Laboratories: Global preclinical CRO providing in-vivo safety, efficacy, and discovery services including alternative model toxicology. Comparable in preclinical CRO services, but vastly larger with global GLP-accredited facilities and a dominant sponsor base.

Emerging players

• Advinus Therapeutics: India-based preclinical CRO with toxicology and drug discovery capabilities. Comparable as a smaller India-headquartered preclinical CRO serving global pharma, but with deeper toxicology focus and Tata group backing.
• Dabur Research Foundation: India-based preclinical and natural product research CRO with phytochemistry and toxicology capabilities. Comparable as a niche India-based CRO with overlap in natural product chemistry and preclinical services, but at larger scale and with longer history.
• Vivo Bio Tech: Hyderabad-based preclinical CRO offering in-vivo pharmacology, toxicology, and alternate animal model services including zebrafish. Comparable as an India-based preclinical CRO using alternative animal models for drug discovery, though with broader disease models and longer operating history.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Simbioen Labs and Scientific Services